Sun Pharma Inds. - Quaterly Results
Date: 06-11-2025
The sales is pegged at Rs. 45481.10 millions for the September 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 51224.70 millions during the year-ago period.A big decline of -32.70% was reported for the quarter ended September 2025 to Rs. 5642.20 millions from Rs. 8383.70 millions of corresponding previous quarter.A decline of 12563.80 millions was observed in the OP in the quarter ended September 2025 from 14270.80 millions on QoQ basis.
| | Quarter ended | Year to Date | Year ended |
| | 202509 | 202409 | % Var | 202509 | 202409 | % Var | 202503 | 202403 | % Var |
| Sales | 45481.10 | 51224.70 | -11.21 | 101500.70 | 96205.40 | 5.50 | 230033.30 | 202751.70 | 13.46 |
| Other Income | 5544.10 | 2237.80 | 147.75 | 8476.20 | 3065.20 | 176.53 | 6239.70 | 4657.60 | 33.97 |
| PBIDT | 12563.80 | 14270.80 | -11.96 | 32512.20 | 22708.90 | 43.17 | 71620.50 | 60533.70 | 18.32 |
| Interest | 2483.30 | 2590.40 | -4.13 | 4716.20 | 4751.20 | -0.74 | 8932.10 | 7840.80 | 13.92 |
| PBDT | 10080.50 | 11680.40 | -13.70 | 24919.60 | 17957.70 | 38.77 | 62688.40 | 50502.70 | 24.13 |
| Depreciation | 3363.00 | 2972.30 | 13.14 | 6353.30 | 6670.40 | -4.75 | 12382.70 | 16006.20 | -22.64 |
| PBT | 6717.50 | 8708.10 | -22.86 | 18566.30 | 11287.30 | 64.49 | 50305.70 | 34496.50 | 45.83 |
| TAX | 1075.30 | 324.40 | 231.47 | 5388.80 | 525.40 | 925.66 | 7479.50 | 5914.70 | 26.46 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 5642.20 | 8383.70 | -32.70 | 13177.50 | 10761.90 | 22.45 | 42826.20 | 28581.80 | 49.84 |
| Equity | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 | 2399.30 | 2399.30 | 0.00 |
| PBIDTM(%) | 27.62 | 27.86 | -0.84 | 32.03 | 23.60 | 35.70 | 31.13 | 29.86 | 4.28 |